Health Care/Hospital
EBR Systems nominated for MTAA Excellence in Medical Technology award
SUNNYVALE, Calif., Oct. 23, 2023 /PRNewswire/ -- EBR Systems, Inc. (ASX:EBR),
the developer of the world's only wireless cardiac pacing device for heart
failure, is pleased to announce it has been named as a nominee for the 2023
Medical Technology Association ofAustralia
2023-10-23 12:26
1744
Cancer Prevention Scholars and Climate Crisis Experts from Korea, US and Japan Come Together, iCOOP KOREA Holds the '2023 International Symposium'
SEOUL, South Korea, Oct. 23, 2023 /PRNewswire/ -- iCOOP KOREA held the
2023-10-23 07:00
2258
CPIC Life (H.K.) Assigned by Moody's An A3 IFSR, Outlook Stable
HONG KONG, Oct. 22, 2023 /PRNewswire/ -- China Pacific Life Insurance (H.K.)
Company Limited ("CPIC Life (HK)" or "the Company") is pleased to announce that
the Company was assigned byMoody's Investors Service
2023-10-22 11:09
2338
Gene Technology Light Up the Future - Opening of the International Conference of Genomics on Eye 2023
SHENYANG, China, Oct. 21, 2023 /PRNewswire/ -- The International Conference of Genomics on Eye 2023 (the "6th ICG Eye") embraced its grand opening in Shenyang on 14th-15th October. The conference, hosted by the Shenyang Municipal People's Government, organized by the Shenyang Bureau of Science a...
2023-10-21 03:12
3555
Striving Together For A Thriving Industry, International Biopharma Industry Week Shanghai 2023 Opens
SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- On October 16th, the inaugural ceremony of the 2023 International Biopharma Industry Week Shanghai (IBIWS 2023) unfolded at the Zhangjiang Science Hall inShanghai. Spanning five days, this event, themed as "Striving Together for A Thriving Industry," endeav...
2023-10-20 15:29
2387
Europlasma NV has filed a lawsuit against Nanowatt BV
FUVEAU, France, Oct. 20, 2023 /PRNewswire/ -- Europlasma NV, a wholly-owned subsidiary of Plasmalex SAS, and a global technology leader in innovative nano-coating solutions based on low pressure plasma technology,has filed a lawsuit against Nanowatt BV as well as its Director Taco 12 BV (represen...
2023-10-20 08:00
2484
Wolters Kluwer Applauded by Frost & Sullivan for Improving Healthcare Efficiencies, Quality, and Outcomes and for Its Competitive Strategies
Wolters Kluwer uniquely leverages its expertise to meet market and customer needs, positioning it to capitalize on new growth opportunities and lead in healthcare conversational AI. SAN ANTONIO, Oct. 19, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the conversational artificial inte...
2023-10-19 21:35
1676
Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)
Endeavor obtains exclusive worldwide rights to Hummingbird Bioscience's anti-HER3 ADC to be developed for patients with HER3-expressing tumors Hummingbird Bioscience to receive upfront and milestone payments up to $430 million, plus royalties, from Endeavor BioMedicines Investigational New Drug ...
2023-10-19 20:18
1909
Qilu Pharmaceutical to Showcase Novel Anti-Cancer Drug QL1706 at ESMO Congress 2023
JINAN, China, Oct. 19, 2023 /PRNewswire/ -- Data from Qilu Pharmaceutical's clinical trial of its novel bifunctional antibody, QL1706 (iparomlimab and tuvonralimab), will be unveiled during a mini oral presentation at the European Society for Medical Oncology (ESMO) Annual Congress 2023. The ESMO...
2023-10-19 19:42
1849
PureSoftware Appoints Industry Veteran Steve Rosenberg as Board Advisor to Strengthen its Life Sciences and Healthcare Vertical
NEW YORK and NOIDA, India, Oct. 19, 2023 /PRNewswire/ -- PureSoftware, a global software and services provider, is proud to announce the appointment ofSteve Rosenberg, a distinguished leader in the Life Sciences and Healthcare technology industry, to its Advisory Board. With a career spanning ove...
2023-10-19 19:00
2115
ProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and Tolerability
* The study has achieved its primary objectives, confirming the safety and tolerability profile of TLX591 administered in two doses, two weeks apart in combination with standard of care (SoC) * Preliminary activity demonstrates meaningful PSA[1] reduction; monitoring of patients is ongoing, i...
2023-10-19 06:01
1727
Dr. Huda Zoghbi Reveals New Research Into the Mechanisms Driving Rett Syndrome at the 2023 World Congress of Neurology
MONTREAL, Oct. 19, 2023 /PRNewswire/ -- Huda Zoghbi, MD, professor of molecular and human genetics,Baylor College of Medicine, has made a groundbreaking discovery in the field of neurology. Her research shows that mutations in the MECP2 gene are responsible for causing Rett syndrome, a childhood ...
2023-10-19 01:09
1624
Frost & Sullivan Recognizes Neuromod Devices with the 2023 New Product Innovation Award for Developing a Robust Solution That Meets Tinnitus Patients' Needs
Neuromod Devices uniquely leverages its sophisticated technology to meet tinnitus patients' dynamic needs and strict global regulatory requirements for medical devices. SAN ANTONIO, Oct. 19, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the neuromodulation devices for tinnitus space ...
2023-10-19 01:03
1734
Driving Innovation in Diagnostics: Fapon's Latest Solutions at Indonesia Hospital Expo 2023
JAKARTA, Indonesia, Oct. 18, 2023 /PRNewswire/ -- Fapon, a leading life-science company, will showcase its latest innovations in IVD core raw materials, reagent services and open instrument platforms at Indonesia Hospital Expo 2023 fromOctober 18 to October 21, 2023. During the exhibition, the co...
2023-10-18 22:47
2361
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® demonstrates no increased risk in major adverse cardiac events in a large, long-term real-world evidence study
BRENTWOOD, Tenn., Oct. 18, 2023 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax") today announced top-line results from a Cardiovascular Health Outcomes Analysis (HOA). This study evaluated the cardiovascular safety of CONTRAVE®/MYSIMBA®, a weight management drug. The real-world study compare...
2023-10-18 20:00
1650
Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore
GAITHERSBURG, Md., Oct. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced thatSingapore's Health Sciences Authority (HSA) has granted full approval for Novavax's prototype COVID-19 vaccine Nuvaxovi...
2023-10-18 20:00
1504
SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science BOSTON and ROLLE, Switzerland, Oct. 18, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in da...
2023-10-18 20:00
1716
Seegene Reinforces Commitment to Strong ESG Management with 100% Recyclable, Styrofoam-Free Shipping Boxes
* 100% recyclable package made with eco-friendly and FSC-certified materials to proactively meet evolving global environmental regulations * Patent design provides a 30% increase in load capacity and an up to 52% reduction in transportation costs * This initiative is part of Seegene's effort...
2023-10-18 19:00
2062
Telix reports fourth consecutive quarter of positive operating cash flow
MELBOURNE, Australia, Oct. 18, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow report and accompanying Activities Report for the quarter ended30 September 2023 (Q3 2023). All figures are in AUD$ unless otherwise s...
2023-10-18 15:42
1504
Yuyu Pharma to attend 'CPHI Worldwide 2023'
SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending
CPHI Worldwide inBarcelona, Spain from October 24th to October 26th.
2023-10-18 15:00
2207
Week's Top Stories
Most Reposted
Thailand Tops 2024 Consumer Review Awards by Agoda
[Picked up by 329 media titles]
2024-09-26 11:00
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
[Picked up by 314 media titles]
2024-09-26 00:00
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
[Picked up by 312 media titles]
2024-09-23 13:37
Circles Partners with Telkomsel, Providing an Advanced Software-as-a-Service (SaaS) Platform to Enhance Customer Digital Experience
[Picked up by 297 media titles]
2024-09-27 10:00RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
[Picked up by 294 media titles]
2024-09-23 22:00
Most Read
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
2024-09-26 00:00
7301
RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
2024-09-23 22:00
6939
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
2024-09-23 13:37
6322
Thailand Tops 2024 Consumer Review Awards by Agoda
2024-09-26 11:00
6086
Sobot Reflects on its Partnership with Lilith Games on Lilith's 11th Anniversary
2024-09-24 10:00
5545
